Melatonin in patients with Atypical Facial Pain

Comparison of the Effectiveness Of Melatonin in patients with Atypical Facial Pain

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20141220020377N4

Enrollment

Registered

2019-08-17

Start date

2019-09-23

Completion date

Unknown

Last updated

2019-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atypical Facial Pain. Atypical facial pain

Interventions

Intervention 1: Intervention group: Intervention group: In intervention group patients will use Melatonin Tab 3 Mg (Iran Construction of A-lHavi Company) 4 times a day for 5 month. Intervention 2: Co

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Pain mouth at all times, Lack of Systemic Disease and chronic medication Patients over 18 years of age No use of Smoking Lack of oral lesion

Exclusion criteria

Exclusion criteria: Elderly people with glaucoma Those who take aspirin or heparin or warfarin Those who take atenolol and metoprolol because they reduce the effect of melatonin Patients with epilepsy

Design outcomes

Primary

Measure	Time frame
Level of Pain. Timepoint: The First Visit, 8 weeks Later, 4 weeks Later,4 weeks Later, 8 weeks Later. Method of measurement: Visual Analogue Scale.;Average sleep disorder. Timepoint: The First Visit, 24 weeks Later. Method of measurement: Questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr.Tahereh Nosratzehi

Zahedan University of Medical Sciences

Nosratzehi@zaums.ac.ir+98 54 3401 3041

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026